At the forefront of unlocking unique biological therapies
Combining decades of scientific and industry experience
eleva is a clinical-stage biopharmaceutical company developing novel therapies and unlocking difficult-to-produce biologics based on a transformative manufacturing platform.
eleva generates value by unlocking and developing unique therapies. The ability to discover and manufacture innovative biologics will only grow in importance in our industry.
Our mission
We harness the outstanding capabilities of our moss-based platform to create candidates no one else can and advance them into clinical development.
Unlocking biologics with transformative moss-based manufacturing
The ability to manufacture biologics effectively and at scale has become a crucial success factor in the pharmaceutical industry – and its importance will only continue to grow. Novel expression strategies can provide access to previously uncharted biologics, improve essential drug properties, and deliver not just “more,” but a superior product from the outset.
eleva is uniquely positioned in these markets with its proprietary moss-based manufacturing platform, which has the potential to unlock difficult-to-produce biological therapies.
We substantiate this claim by independently advancing a portfolio of therapeutic candidates into clinical development and attracting partners for de novo projects. Factor H (CPV-104), our recombinant version of human complement Factor H, is expected to enter clinical studies for its lead indication, C3 Glomerulopathy (C3G), in the first half of 2025. Additionally, our recombinant version of α-galactosidase aGal (RPV-001) has already demonstrated promising initial clinical data in Fabry disease.
All programs are derived from eleva’s transformative moss-based expression system, which enables lab-to-GMP-scale manufacturing of challenging proteins with refined and optimized product characteristics. We believe there are numerous opportunities in our industry that would benefit from a synergistic expression strategy and platform integrated from the start and throughout the entire product development roadmap.
